|
Most
common toxicities for all patients who received FL.
|
Toxicity
|
Cohort
1
(n=9)
|
Cohort
2
(n=10)
|
Cohort
3
(n=8)
|
|
CTC
Grade
|
|
1/2
|
3/4
|
1/2
|
3/4
|
1/2
|
3/4
|
|
Lethargy
|
4
|
1
|
6
|
2
|
6
|
-
|
|
FL injection site reaction
|
6
|
-
|
4
|
-
|
6
|
-
|
|
Monocytosis
|
6
|
-
|
4
|
-
|
6
|
-
|
|
URTI symptoms a
|
4
|
-
|
6
|
-
|
3
|
-
|
|
Fever
|
3
|
-
|
6
|
-
|
2
|
-
|
|
Headache
|
4
|
-
|
2
|
-
|
4
|
-
|
|
Anemia
|
3
|
-
|
3
|
-
|
2
|
-
|
|
Nausea or vomiting
|
2
|
-
|
3
|
-
|
2
|
-
|
|
Thrombocytopenia
|
2
|
-
|
2
|
-
|
3
|
-
|
|
Arthralgias
|
2
|
-
|
1
|
-
|
3
|
-
|
|
Pain - abdominal, NOS b
|
1
|
-
|
3
|
-
|
2
|
-
|
|
Pain - musculoskeletal
|
1
|
-
|
2
|
1
|
2
|
-
|
|
Cough
|
2
|
-
|
2
|
-
|
1
|
-
|
|
Flu-like illness
|
1
|
-
|
2
|
-
|
2
|
-
|
|
Lymphopenia
|
3
|
-
|
2
|
-
|
-
|
-
|
|
Myalgias
|
2
|
-
|
3
|
-
|
-
|
-
|
|
Peptide injection site reaction
|
-
|
-
|
1
|
-
|
4
|
-
|
|
Diarrhea
|
2
|
-
|
1
|
-
|
1
|
-
|
|
Eosinophilia
|
1
|
-
|
2
|
-
|
1
|
-
|
|
Lymphadenopathy
|
2
|
-
|
1
|
-
|
1
|
-
|
|
Sweats
|
-
|
-
|
3
|
-
|
1
|
-
|
|
Anorexia
|
-
|
-
|
3
|
-
|
-
|
-
|
|
Old scar inflammation
|
1
|
-
|
2
|
-
|
-
|
-
|
|
Skin rash
|
-
|
-
|
1
|
-
|
2
|
-
|
|
Thrombocytosis
|
-
|
-
|
2
|
-
|
1
|
-
|
a
Upper respiratory tract infection (URTI) symptoms, including sore
throat, rhinorrhea, or sinusitis.
b Not otherwise specified.
|